Shared genetic susceptibility to breast cancer, brain tumors, and Fanconi anemia

Kenneth Offit, Orna Levran, Brian Mullaney, Katherine Mah, Khedoudja Nafa, Sat Dev Batish, Raffaella Diotti, Hildegard Scheider, Amie Deffenbaugh, Thomas Scholl, Virginia K. Proud, Mark Robson, Larry Norton, Nathan Ellis, Helmut Hanenberg, Arleen D. Auerbach

Research output: Contribution to journalArticle

132 Citations (Scopus)

Abstract

Fanconi anemia is an inherited disease characterized by bone marrow failure, congenital malformations, and predisposition to cancer. The breast cancer susceptibility gene BRCA2 was recently found to be associated with Fanconi anemia complementation group D1 (FA-D1). We examined four kindreds afflicted with Fanconi anemia for the presence of germline BRCA2 mutations. One kindred, of Ashkenazi Jewish ancestry, had five members who were diagnosed with breast cancer and two cousins who were BRCA2*6174delT/ C3069X compound heterozygotes and had Fanconi anemia and brain tumors. In another kindred of Ashkenazi Jewish and Lithuanian Catholic ancestry, a child with Fanconi anemia and a medulloblastoma was a BRCA2*6174delT/886delGT compound heterozygote. Two other kindreds each contained a Fanconi anemia-afflicted child who developed medulloblastoma; one child was of Latin American ancestry and a compound heterozygote for BRCA2*I2490T/ 5301insA and the other was African American and a compound heterozygote for BRCA2*Q3066X/E1308X. Median age of the Fanconi anemia-afflicted children at brain tumor diagnosis was 3.5 years. The co-occurrence of brain tumors, Fanconi anemia, and breast cancer observed in one of these kindreds constitutes a new syndromic association. Individuals who carry a germline BRCA2 mutation and who plan to have children with a partner of Ashkenazi Jewish descent should consider undergoing genetic counseling.

Original languageEnglish (US)
Pages (from-to)1548-1551
Number of pages4
JournalJournal of the National Cancer Institute
Volume95
Issue number20
StatePublished - Oct 15 2003
Externally publishedYes

Fingerprint

Fanconi Anemia
Genetic Predisposition to Disease
Brain Neoplasms
Breast Neoplasms
Heterozygote
Medulloblastoma
Germ-Line Mutation
Bone Marrow Diseases
Neoplasm Genes
Genetic Counseling
African Americans

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Offit, K., Levran, O., Mullaney, B., Mah, K., Nafa, K., Batish, S. D., ... Auerbach, A. D. (2003). Shared genetic susceptibility to breast cancer, brain tumors, and Fanconi anemia. Journal of the National Cancer Institute, 95(20), 1548-1551.

Shared genetic susceptibility to breast cancer, brain tumors, and Fanconi anemia. / Offit, Kenneth; Levran, Orna; Mullaney, Brian; Mah, Katherine; Nafa, Khedoudja; Batish, Sat Dev; Diotti, Raffaella; Scheider, Hildegard; Deffenbaugh, Amie; Scholl, Thomas; Proud, Virginia K.; Robson, Mark; Norton, Larry; Ellis, Nathan; Hanenberg, Helmut; Auerbach, Arleen D.

In: Journal of the National Cancer Institute, Vol. 95, No. 20, 15.10.2003, p. 1548-1551.

Research output: Contribution to journalArticle

Offit, K, Levran, O, Mullaney, B, Mah, K, Nafa, K, Batish, SD, Diotti, R, Scheider, H, Deffenbaugh, A, Scholl, T, Proud, VK, Robson, M, Norton, L, Ellis, N, Hanenberg, H & Auerbach, AD 2003, 'Shared genetic susceptibility to breast cancer, brain tumors, and Fanconi anemia', Journal of the National Cancer Institute, vol. 95, no. 20, pp. 1548-1551.
Offit K, Levran O, Mullaney B, Mah K, Nafa K, Batish SD et al. Shared genetic susceptibility to breast cancer, brain tumors, and Fanconi anemia. Journal of the National Cancer Institute. 2003 Oct 15;95(20):1548-1551.
Offit, Kenneth ; Levran, Orna ; Mullaney, Brian ; Mah, Katherine ; Nafa, Khedoudja ; Batish, Sat Dev ; Diotti, Raffaella ; Scheider, Hildegard ; Deffenbaugh, Amie ; Scholl, Thomas ; Proud, Virginia K. ; Robson, Mark ; Norton, Larry ; Ellis, Nathan ; Hanenberg, Helmut ; Auerbach, Arleen D. / Shared genetic susceptibility to breast cancer, brain tumors, and Fanconi anemia. In: Journal of the National Cancer Institute. 2003 ; Vol. 95, No. 20. pp. 1548-1551.
@article{e8ad0135f56746c8ae261e92299bf6c0,
title = "Shared genetic susceptibility to breast cancer, brain tumors, and Fanconi anemia",
abstract = "Fanconi anemia is an inherited disease characterized by bone marrow failure, congenital malformations, and predisposition to cancer. The breast cancer susceptibility gene BRCA2 was recently found to be associated with Fanconi anemia complementation group D1 (FA-D1). We examined four kindreds afflicted with Fanconi anemia for the presence of germline BRCA2 mutations. One kindred, of Ashkenazi Jewish ancestry, had five members who were diagnosed with breast cancer and two cousins who were BRCA2*6174delT/ C3069X compound heterozygotes and had Fanconi anemia and brain tumors. In another kindred of Ashkenazi Jewish and Lithuanian Catholic ancestry, a child with Fanconi anemia and a medulloblastoma was a BRCA2*6174delT/886delGT compound heterozygote. Two other kindreds each contained a Fanconi anemia-afflicted child who developed medulloblastoma; one child was of Latin American ancestry and a compound heterozygote for BRCA2*I2490T/ 5301insA and the other was African American and a compound heterozygote for BRCA2*Q3066X/E1308X. Median age of the Fanconi anemia-afflicted children at brain tumor diagnosis was 3.5 years. The co-occurrence of brain tumors, Fanconi anemia, and breast cancer observed in one of these kindreds constitutes a new syndromic association. Individuals who carry a germline BRCA2 mutation and who plan to have children with a partner of Ashkenazi Jewish descent should consider undergoing genetic counseling.",
author = "Kenneth Offit and Orna Levran and Brian Mullaney and Katherine Mah and Khedoudja Nafa and Batish, {Sat Dev} and Raffaella Diotti and Hildegard Scheider and Amie Deffenbaugh and Thomas Scholl and Proud, {Virginia K.} and Mark Robson and Larry Norton and Nathan Ellis and Helmut Hanenberg and Auerbach, {Arleen D.}",
year = "2003",
month = "10",
day = "15",
language = "English (US)",
volume = "95",
pages = "1548--1551",
journal = "Journal of the National Cancer Institute",
issn = "0027-8874",
publisher = "Oxford University Press",
number = "20",

}

TY - JOUR

T1 - Shared genetic susceptibility to breast cancer, brain tumors, and Fanconi anemia

AU - Offit, Kenneth

AU - Levran, Orna

AU - Mullaney, Brian

AU - Mah, Katherine

AU - Nafa, Khedoudja

AU - Batish, Sat Dev

AU - Diotti, Raffaella

AU - Scheider, Hildegard

AU - Deffenbaugh, Amie

AU - Scholl, Thomas

AU - Proud, Virginia K.

AU - Robson, Mark

AU - Norton, Larry

AU - Ellis, Nathan

AU - Hanenberg, Helmut

AU - Auerbach, Arleen D.

PY - 2003/10/15

Y1 - 2003/10/15

N2 - Fanconi anemia is an inherited disease characterized by bone marrow failure, congenital malformations, and predisposition to cancer. The breast cancer susceptibility gene BRCA2 was recently found to be associated with Fanconi anemia complementation group D1 (FA-D1). We examined four kindreds afflicted with Fanconi anemia for the presence of germline BRCA2 mutations. One kindred, of Ashkenazi Jewish ancestry, had five members who were diagnosed with breast cancer and two cousins who were BRCA2*6174delT/ C3069X compound heterozygotes and had Fanconi anemia and brain tumors. In another kindred of Ashkenazi Jewish and Lithuanian Catholic ancestry, a child with Fanconi anemia and a medulloblastoma was a BRCA2*6174delT/886delGT compound heterozygote. Two other kindreds each contained a Fanconi anemia-afflicted child who developed medulloblastoma; one child was of Latin American ancestry and a compound heterozygote for BRCA2*I2490T/ 5301insA and the other was African American and a compound heterozygote for BRCA2*Q3066X/E1308X. Median age of the Fanconi anemia-afflicted children at brain tumor diagnosis was 3.5 years. The co-occurrence of brain tumors, Fanconi anemia, and breast cancer observed in one of these kindreds constitutes a new syndromic association. Individuals who carry a germline BRCA2 mutation and who plan to have children with a partner of Ashkenazi Jewish descent should consider undergoing genetic counseling.

AB - Fanconi anemia is an inherited disease characterized by bone marrow failure, congenital malformations, and predisposition to cancer. The breast cancer susceptibility gene BRCA2 was recently found to be associated with Fanconi anemia complementation group D1 (FA-D1). We examined four kindreds afflicted with Fanconi anemia for the presence of germline BRCA2 mutations. One kindred, of Ashkenazi Jewish ancestry, had five members who were diagnosed with breast cancer and two cousins who were BRCA2*6174delT/ C3069X compound heterozygotes and had Fanconi anemia and brain tumors. In another kindred of Ashkenazi Jewish and Lithuanian Catholic ancestry, a child with Fanconi anemia and a medulloblastoma was a BRCA2*6174delT/886delGT compound heterozygote. Two other kindreds each contained a Fanconi anemia-afflicted child who developed medulloblastoma; one child was of Latin American ancestry and a compound heterozygote for BRCA2*I2490T/ 5301insA and the other was African American and a compound heterozygote for BRCA2*Q3066X/E1308X. Median age of the Fanconi anemia-afflicted children at brain tumor diagnosis was 3.5 years. The co-occurrence of brain tumors, Fanconi anemia, and breast cancer observed in one of these kindreds constitutes a new syndromic association. Individuals who carry a germline BRCA2 mutation and who plan to have children with a partner of Ashkenazi Jewish descent should consider undergoing genetic counseling.

UR - http://www.scopus.com/inward/record.url?scp=0142054687&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0142054687&partnerID=8YFLogxK

M3 - Article

C2 - 14559878

AN - SCOPUS:0142054687

VL - 95

SP - 1548

EP - 1551

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

SN - 0027-8874

IS - 20

ER -